Skip to Content
New To Chronic Myeloid Leukemia? Get Information Today >>

Ioversol Pregnancy and Breastfeeding Warnings

Ioversol is also known as: Optiray 160, Optiray 240, Optiray 300, Optiray 320, Optiray 350

Ioversol Pregnancy Warnings

It is not known whether ioversol crosses the placental barrier or reaches fetal tissues. However, many injectable contrast agents cross the placental barrier in humans and appear to enter fetal tissue passively. X-ray procedures involve a certain risk related to the exposure of the fetus.

Ioversol has been assigned to pregnancy category B by the FDA. Animal studies have revealed no teratogenic effects. There are no controlled data in human pregnancy. Ioversol should be given during pregnancy when need has been clearly established.

See references

Ioversol Breastfeeding Warnings

There are no data on the excretion of ioversol into human milk. Many injectable contrast agents are excreted unchanged in human milk. Because of the potential for adverse reactions, caution is recommended when intravascular contrast media are administered to nursing women and consideration should be given to temporarily discontinuing nursing.

See references

References for pregnancy information

  1. "Product Information. Optiray 350 (ioversol)." Mallinckrodt Medical Inc, St. Louis, MO.

References for breastfeeding information

  1. "Product Information. Optiray 350 (ioversol)." Mallinckrodt Medical Inc, St. Louis, MO.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.